Literature DB >> 12071633

Cell proliferation and tumors of the central nervous system. Part 1: Evaluation of mitotic activity.

Richard A Prayson1.   

Abstract

Evaluation of cell proliferation has been long recognized in pathology as a mainstay of diagnosis and important in the prognostication of a variety of neoplasms. Routine light microscopic evaluation of mitotic activity has long served as a reasonable assessment of cell proliferation. Counting mitotic figures has the advantage of being inexpensive and relatively quick. The main objections leveled against utilization of mitosis counts in diagnostic decision making are related to the instability of mitotic figures due to prefixation and fixation issues and problems with interobserver reproducibility of counts. This paper reviews factors that affect the identification of mitotic figures and the determination of mitosis counts. The role mitosis evaluation plays in the evaluation of certain neoplasms of the central nervous system is discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12071633     DOI: 10.1093/jnen/61.6.501

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

1.  The histopathological spectrum of human meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

2.  Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study.

Authors:  Andreas H Habberstad; Sasha Gulati; Sverre H Torp
Journal:  Diagn Pathol       Date:  2011-05-24       Impact factor: 2.644

3.  Angiogenesis and radiological tumor growth in patients with glioblastoma.

Authors:  Vilde Elisabeth Mikkelsen; Anne Line Stensjøen; Unn Sophie Granli; Erik Magnus Berntsen; Øyvind Salvesen; Ole Solheim; Sverre Helge Torp
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

4.  The histological representativeness of glioblastoma tissue samples.

Authors:  Vilde Elisabeth Mikkelsen; Ole Solheim; Øyvind Salvesen; Sverre Helge Torp
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

5.  Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II.

Authors:  Tove Lind-Landström; Rosilin K Varughese; Stein Sundstrøm; Sverre H Torp
Journal:  Diagn Pathol       Date:  2013-04-24       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.